kidney cancer: minimizing toxicities and hassle in adjuvant therapy
Published 4 years ago • 83 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
1:11
current standard of adjuvant therapy in kidney cancer
-
0:51
novel immune therapeutics for adjuvant treatment of kidney cancer
-
2:35
adjuvant therapy in rcc: harnessing prognostic information
-
0:35
the latest developments in adjuvant therapy for rcc
-
2:23
s-trac phase iii trial of sunitinib as adjuvant therapy in high-risk renal cell cancer patients
-
1:46
clinical trials in kidney cancer to look out for
-
1:03
potential of adjuvant therapy for rcc
-
1:59
key objectives in kidney cancer: treatment sequencing & refining clinical endpoints
-
0:54
advances in the development of targeted therapies for renal cell carcinoma
-
1:12
papillary kidney cancer: prognosis & therapy efficacy
-
4:15
the unmet needs of kidney cancer treatment
-
0:59
updates in kidney cancer at esmo 2022
-
1:08
clinical trials in adjuvant rcc
-
4:33
adjuvant checkpoint blockade in high-risk urothelial and kidney cancer
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
26:50
management of toxicities related to systemic therapy for metastatic renal cell carcinoma
-
2:37
key unmet needs in kidney cancer
-
28:07
management of locally advanced rcc (lnd, ivc, thrombus, adjuvant, neoadjuvant therapy)
-
0:35
potential of immunotherapy for kidney cancer